Cited by — Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE trials | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE trials.
No admitted local citation edges point to this work yet.
